Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors ...

Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Thoracic medical oncologists and early drug development specialists at Memorial Sloan Kettering Cancer Center (MSK) continue to investigate new ways to improve outcomes for this patient population.

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses the latest advancements in HR+/HER2– breast cancer research, as well as the ...

Chemotherapy is one of the most commonly used treatments for cancer, but it can cause side effects. Alternatives include surgery, targeted therapy, and laser therapy. More than 100 types of cancer ...

Bioengineering aims to improve targeted cancer therapies by enhancing drug delivery, boosting immune responses, and refining surgical techniques. The field is highly interdisciplinary, merging ...

Joey Carlsen Martinez was treated at MSK for Erdheim-Chester disease, a rare form of blood cancer. He received an experimental drug called ulixertinib as part of a single-patient clinical trial. The ...